Summary by Moomoo AI
On June 7, 2024, SciClone Pharmaceuticals Holding Limited (SciClone Pharmaceuticals-B) submitted the disclosure report to be disclosed the next day, which disclosed the details of the company's share repurchase. According to the report, SciClone Pharmaceuticals-B made several share repurchases through the Hong Kong Stock Exchange from May 31 to June 7, 2024, with a total repurchase of 1,394,000 shares, accounting for 0.242% of the total issued shares at the time. Among them, 263,500 shares were repurchased on June 7, at a price per share ranging from HKD 5.92 to HKD 6.1, with a total repurchase amount of HKD 1,592,665. After the repurchase, the company's total issued shares remained at 575,653,415 shares. The action has received formal authorization and approval from the board of directors and complies with the relevant rules of the Hong Kong Stock Exchange.